TSXV:TEST

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries.


Snowflake Analysis

Adequate balance sheet and overvalued.

Share Price & News

How has FluroTech's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TEST's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-22.7%

TEST

5.3%

CA Electronic

2.7%

CA Market


1 Year Return

-75.0%

TEST

-10.1%

CA Electronic

-11.5%

CA Market

Return vs Industry: TEST underperformed the Canadian Electronic industry which returned -10.1% over the past year.

Return vs Market: TEST underperformed the Canadian Market which returned -11.5% over the past year.


Shareholder returns

TESTIndustryMarket
7 Day-22.7%5.3%2.7%
30 Day-34.6%12.9%1.6%
90 Day-10.5%6.2%-8.4%
1 Year-75.0%-75.0%-10.1%-10.1%-8.5%-11.5%
3 Yearn/a-47.0%-47.0%-0.5%-9.8%
5 Yearn/a-30.3%-30.3%14.6%-2.4%

Price Volatility Vs. Market

How volatile is FluroTech's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is FluroTech undervalued compared to its fair value and its price relative to the market?

1.92x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate TEST's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate TEST's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: TEST is unprofitable, so we can't compare its PE Ratio to the Electronic industry average.

PE vs Market: TEST is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TEST's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TEST is good value based on its PB Ratio (1.9x) compared to the CA Electronic industry average (2.1x).


Next Steps

Future Growth

How is FluroTech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

98.8%

Forecasted Tech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as FluroTech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has FluroTech performed over the past 5 years?

14.0%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: TEST is currently unprofitable.

Growing Profit Margin: TEST is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if TEST's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare TEST's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TEST is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-9.5%).


Return on Equity

High ROE: TEST has a negative Return on Equity (-210.63%), as it is currently unprofitable.


Next Steps

Financial Health

How is FluroTech's financial position?


Financial Position Analysis

Short Term Liabilities: TEST's short term assets (CA$2.3M) exceed its short term liabilities (CA$412.4K).

Long Term Liabilities: TEST's short term assets (CA$2.3M) exceed its long term liabilities (CA$1,000.0).


Debt to Equity History and Analysis

Debt Level: TEST is debt free.

Reducing Debt: TEST had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TEST has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: TEST has less than a year of cash runway if free cash flow continues to reduce at historical rates of 38.9% each year


Next Steps

Dividend

What is FluroTech's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate TEST's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TEST's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TEST's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TEST's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TEST's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average management tenure


CEO

Danny Dalla-Longa (65yo)

1.75yrs

Tenure

CA$169,833

Compensation

Mr. Danny D. Dalla-Longa, CPA, serves as Vice President of Corporate Finance at i3 Capital Partners, Inc. He was Vice President of Corporate Finance at i3 Capital Partners Inc., Investment Arm. Prior to jo ...


CEO Compensation Analysis

Compensation vs Market: Danny's total compensation ($USD123.02K) is about average for companies of similar size in the Canadian market ($USD158.99K).

Compensation vs Earnings: Danny's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Danny Dalla-Longa
Co-Founder1.75yrsCA$169.83k1.69% CA$78.1k
Curtis Smith
Chief Financial Officer1.5yrsCA$159.59k0.41% CA$18.7k
Derek Clark
Executive Commercialization Consultant1.92yrsno datano data

1.8yrs

Average Tenure

Experienced Management: TEST's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Danny Dalla-Longa
Co-Founder1.75yrsCA$169.83k1.69% CA$78.1k
Sidney Dutchak
Chairman of the Boardno dataCA$13.57k0.018% CA$850.2
Elmar Prenner
Member of the Advisory Board0.083yrCA$149.00kno data
Richard Hanson
Independent Director2yrsCA$12.82kno data
Raimer Lodenburg
Member of Advisory Boardno datano datano data
John Conroy
Member of Advisory Boardno datano datano data
Imre Kovacs
Member of Advisory Boardno datano datano data

2.0yrs

Average Tenure

Experienced Board: TEST's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

FluroTech Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: FluroTech Ltd.
  • Ticker: TEST
  • Exchange: TSXV
  • Founded:
  • Industry: Electronic Equipment and Instruments
  • Sector: Tech
  • Market Cap: CA$4.613m
  • Shares outstanding: 54.27m
  • Website: https://www.flurotech.com

Number of Employees


Location

  • FluroTech Ltd.
  • 7-3535 Research Road NW
  • Calgary
  • Alberta
  • T2L 1Y1
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TESTTSXV (TSX Venture Exchange)YesCommon SharesCACADJun 2018
FLUR.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 2018

Biography

FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech’s specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/05/30 06:46
End of Day Share Price2020/05/29 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.